Organelle Stress and Glycation in Kidney Disease

Overview

Journal Glycoconj J

Publisher Springer

Specialties Biochemistry
Endocrinology

Date 2021 Mar 12

PMID 33709200

Citations 4

Authors

Reiko Inagi

Affiliations

Soon will be listed here.

Abstract

Glycation of proteins is a non-enzymatic posttranslational modification. Such random modification often deranges the structure and function of a wide range of proteins, and in turn leads to cellular dysfunction and organ damage. Protein glycation is thus an important topic in understanding the molecular mechanisms of the development or progression of various kinds of diabetes-related diseases. Meanwhile, organelle stress, such as mitochondrial or endoplasmic reticulum (ER) damage, is a causal factor for cellular dysfunction. Under pathogenic conditions, mitochondrial stress and ER stress are induced by glycated proteins. Intensive research has revealed the molecular mechanism of how glycation contributes to cell fate via organelle stress. This article will summarize the most recent evidence on organelle stress and glycation in kidney disease, especially diabetic kidney disease (DKD) associated with high glycation status.

Citing Articles

Oleanolic acid and its analogues: promising therapeutics for kidney disease.

Pan D, Qu Y, Shi C, Xu C, Zhang J, Du H Chin Med. 2024; 19(1):74.

PMID: 38816880 PMC: 11140902. DOI: 10.1186/s13020-024-00934-w.

Functioning and mechanisms of PTMs in renal diseases.

Liu Z, Yang J, Du M, Xin W Front Pharmacol. 2023; 14:1238706.

PMID: 38074159 PMC: 10702752. DOI: 10.3389/fphar.2023.1238706.

The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation.

Xu L, Zhou Y, Wang G, Bo L, Jin B, Dai L Cell Death Dis. 2023; 14(2):166.

PMID: 36849424 PMC: 9971188. DOI: 10.1038/s41419-023-05685-4.

Stratification of diabetic kidney diseases data-independent acquisition proteomics-based analysis of human kidney tissue specimens.

Huang Q, Fei X, Zhong Z, Zhou J, Gong J, Chen Y Front Endocrinol (Lausanne). 2022; 13:995362.

PMID: 36465646 PMC: 9714485. DOI: 10.3389/fendo.2022.995362.

References

Brownlee M, Vlassara H, Cerami A . Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 1984; 101(4):527-37. DOI: 10.7326/0003-4819-101-4-527. View

Verzola D, Milanesi S, Viazzi F, Ansaldo F, Saio M, Garibaldi S . Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy. Sci Rep. 2020; 10(1):6343. PMC: 7156449. DOI: 10.1038/s41598-020-62875-2. View

Goh S, Cooper M . Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008; 93(4):1143-52. DOI: 10.1210/jc.2007-1817. View

Gugliucci A, Bendayan M . Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia. 1996; 39(2):149-60. DOI: 10.1007/BF00403957. View

Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, Van Ypersele De Strihou C . Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int. 1998; 53(2):416-22. DOI: 10.1046/j.1523-1755.1998.00756.x. View

Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R . Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010; 110(6):911-16.e12. PMC: 3704564. DOI: 10.1016/j.jada.2010.03.018. View

Stinghen A, Massy Z, Vlassara H, Striker G, Boullier A . Uremic Toxicity of Advanced Glycation End Products in CKD. J Am Soc Nephrol. 2015; 27(2):354-70. PMC: 4731113. DOI: 10.1681/ASN.2014101047. View

Vlassara H, Striker L, Teichberg S, Fuh H, Li Y, Steffes M . Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A. 1994; 91(24):11704-8. PMC: 45300. DOI: 10.1073/pnas.91.24.11704. View

Tanji N, Markowitz G, Fu C, Kislinger T, Taguchi A, Pischetsrieder M . Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol. 2000; 11(9):1656-1666. DOI: 10.1681/ASN.V1191656. View

10.

Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H . Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1998; 100(12):2995-3004. PMC: 508511. DOI: 10.1172/JCI119853. View

11.

Inagi R . Glycative stress and glyoxalase in kidney disease and aging. Biochem Soc Trans. 2014; 42(2):457-60. DOI: 10.1042/BST20140007. View

12.

Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R . Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A. 1992; 89(24):12043-7. PMC: 50694. DOI: 10.1073/pnas.89.24.12043. View

13.

Tang S, Leung J, Chan L, Tsang A, Lai K . Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. J Am Soc Nephrol. 2006; 17(6):1633-43. DOI: 10.1681/ASN.2005101113. View

14.

Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G . Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007; 62(4):427-33. PMC: 2645629. DOI: 10.1093/gerona/62.4.427. View

15.

Lee H, Yu M, Yang Y, Jiang Z, Ha H . Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(8 Suppl 3):S241-5. DOI: 10.1097/01.asn.0000077410.66390.0f. View

16.

Himmelfarb J, Stenvinkel P, Ikizler T, Hakim R . The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62(5):1524-38. DOI: 10.1046/j.1523-1755.2002.00600.x. View

17.

Wautier M, Chappey O, Corda S, STERN D, Schmidt A, Wautier J . Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab. 2001; 280(5):E685-94. DOI: 10.1152/ajpendo.2001.280.5.E685. View

18.

Coughlan M, Thorburn D, Penfold S, Laskowski A, Harcourt B, Sourris K . RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol. 2009; 20(4):742-52. PMC: 2663823. DOI: 10.1681/ASN.2008050514. View

19.

Yan S, Schmidt A, Anderson G, Zhang J, Brett J, Zou Y . Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994; 269(13):9889-97. View

20.

Ramasamy R, Vannucci S, Yan S, Herold K, Yan S, Schmidt A . Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005; 15(7):16R-28R. DOI: 10.1093/glycob/cwi053. View